Albany Molecular, Marvel, STEC: U.S. Small-Cap Equity Movers

The Russell 2000 Index fell for a second day, losing 0.2 percent to 724.48 at 10:49 a.m. in New York. The Standard & Poor's 500 Index (SPX), whose companies have a median market value 22 times larger than the Russell 2000, slipped 0.3 percent. The stock indexes have declined 4 percent and 5.4 percent, respectively, this year.

Albany Molecular Research Inc. (AMRI) jumped 16 percent, the most since Aug. 10, to $13.29. The medical research contractor said profit for the year may be as high as 42 cents a share, exceeding the average analyst estimate for earnings of 33 cents a share.

INX Inc. (INXI US) had the steepest gain since November 2003, adding 21 percent to $9.45. The reseller of Cisco Systems Inc. data-networking products reported first-quarter sales that exceeded analysts' estimates.

Marvel Entertainment Inc. (MVL US) rose 7.1 percent to $32.39 for the biggest increase since Nov. 5. The movie and comic book producer increased its forecast for 2008 adjusted earnings to $1.35 to $1.55 a share on sales of $370 million to $400 million. Previously, it predicted profit of $1.30 to $1.50 on revenue of $360 million to $400 million.

STEC Inc. (STEC) gained 18 percent, the most since July 17, to $10.98. The maker of flash-memory devices said second-quarter profit may be as high as 8 cents a share, exceeding the average analyst estimate of 5 cents a share. The company also reported first-quarter earnings that topped estimates.

To contact the reporter on this story: Lynn Thomasson in New York at lthomasson@bloomberg.net.

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.